Ad is loading...
PGEYX
Price
$26.65
Change
-$0.24 (-0.89%)
Updated
Nov 15 closing price
RLEFX
Price
$36.11
Change
-$0.33 (-0.91%)
Updated
Nov 15 closing price
Ad is loading...

PGEYX vs RLEFX

Header iconPGEYX vs RLEFX Comparison
Open Charts PGEYX vs RLEFXBanner chart's image
George Putnam Balanced Y
Price$26.65
Change-$0.24 (-0.89%)
VolumeN/A
CapitalizationN/A
American Funds American Balanced R5E
Price$36.11
Change-$0.33 (-0.91%)
VolumeN/A
CapitalizationN/A
PGEYX vs RLEFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PGEYX vs. RLEFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PGEYX is a StrongBuy and RLEFX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RLEFX has more cash in the bank: 236B vs. PGEYX (2.11B). RLEFX pays higher dividends than PGEYX: RLEFX (2.42) vs PGEYX (1.32). PGEYX was incepted earlier than RLEFX: PGEYX (31 years) vs RLEFX (9 years). RLEFX is a more actively managed with annual turnover of: 171.00 vs. PGEYX (47.00). PGEYX has a lower initial minimum investment than RLEFX: PGEYX (0) vs RLEFX (250). PGEYX annual gain was more profitable for investors over the last year : 23.63 vs. RLEFX (21.09). RLEFX (35.95) and PGEYX (34.24) have equivalent 5 years return.
PGEYXRLEFXPGEYX / RLEFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence31 years9 years-
Gain YTD16.98814.211120%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.11B236B1%
Annual Yield % from dividends1.322.4255%
Returns for 1 year23.6321.09112%
Returns for 3 years7.7010.9570%
Returns for 5 years34.2435.9595%
Returns for 10 years81.62N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SKYW111.330.52
+0.47%
SkyWest
TCBK47.59-0.02
-0.04%
TriCo Bancshares
WIT6.72-0.07
-1.03%
Wipro Limited
EDAP2.45-0.07
-2.78%
EDAP TMS SA
ELEV0.53-0.05
-8.41%
Elevation Oncology